The Food and Drug Administration (FDA) has released “Considering Whether an FDA-Regulated Product Involves the Application of Nanotechnology,” a draft guidance document available for comment. The goal is “to provide regulated industries with greater certainty about the use of nanotechnology. Read more.
FDA releases draft guideline related to nanotechnology
Most Recent Content
For Nurse Practitioners
Quiz: Migraines and Hormones
Women are 2 to 3 times more likely than men to have migraines. Decades ago, these were attributed to women’s inability to cope with...
